Literature DB >> 15905287

Molecular forms and microheterogeneity of the oligosaccharide chains of pregnancy-associated CA125 antigen.

Miroslava M Jankovic1, Bojana S Tapuskovic.   

Abstract

BACKGROUND: The cancer antigen CA125 has a very complex molecular architecture in terms of both protein backbone and oligosaccharide chains. In this study, we examined the molecular forms and microheterogeneity of oligosaccharide chains of pregnancy-associated CA125, as a first step towards gaining an insight into its possible involvement as a ligand in carbohydrate-dependent interactions. The glycobiochemical properties of CA125 may be of diagnostic and biomedical importance as specific markers of physiological and pathological conditions of early pregnancy, as well as targets in different therapeutic procedures.
METHODS: Pregnancy-associated CA125 was characterized by gel filtration and ion-exchange chromatography, followed by lectin-affinity chromatography with a panel of plant lectins as ligands.
RESULTS: CA125 antigen isolated from first trimester placental extract was found to be heterogeneous in respect to molecular mass and the existence of different glyco-isoforms. Thus, elution profiles from the lectin-affinity columns demonstrated molecular subpopulations bound with low, intermediate and high affinity. Under the applied experimental conditions, CA125 bound most strongly to Triticum vulgaris agglutinin (WGA) and Ricinus communis agglutinin (RCA), but low affinity interactions occurred with the other lectins tested.
CONCLUSIONS: The assessment of the carbohydrate composition of N- and O-glycans of pregnancy-associated CA125 was in general agreement with available data on CA125 of cancer origin. The main difference was observed in reactivity to Canavalia ensiformis agglutinin (ConA) and Phaseolus vulgaris erythroagglutinin (PHA-E) binding.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15905287     DOI: 10.1093/humrep/dei095

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  9 in total

1.  CA125 in ovarian cancer.

Authors:  Nathalie Scholler; Nicole Urban
Journal:  Biomark Med       Date:  2007-12       Impact factor: 2.851

2.  Biochemical and morphological differences between CA125 isolated from healthy women and patients with epithelial ovarian cancer from Tunisian population.

Authors:  Houda Bouanène; Walid Saibi; Moncef Mokni; Badreddine Sriha; L Ben Fatma; H Ben Limem; S Ben Ahmed; Ali Gargouri; Abdelhédi Miled
Journal:  Pathol Oncol Res       Date:  2011-09-07       Impact factor: 3.201

3.  Why is influenza virus more risky for pregnant women?

Authors:  Maria Grazia Cusi
Journal:  Influenza Other Respir Viruses       Date:  2010-09       Impact factor: 4.380

Review 4.  Deciphering the molecular nature of ovarian cancer biomarker CA125.

Authors:  Florian Weiland; Karina Martin; Martin K Oehler; Peter Hoffmann
Journal:  Int J Mol Sci       Date:  2012-08-22       Impact factor: 6.208

5.  MUC16/CA125 in the context of modular proteins with an annotated role in adhesion-related processes: in silico analysis.

Authors:  Miroslava Jankovic; Ninoslav Mitic
Journal:  Int J Mol Sci       Date:  2012-08-21       Impact factor: 6.208

6.  Exploring the glycosylation of serum CA125.

Authors:  Radka Saldova; Weston B Struwe; Kieran Wynne; Giuliano Elia; Michael J Duffy; Pauline M Rudd
Journal:  Int J Mol Sci       Date:  2013-07-26       Impact factor: 5.923

Review 7.  MUC16 (CA125): tumor biomarker to cancer therapy, a work in progress.

Authors:  Mildred Felder; Arvinder Kapur; Jesus Gonzalez-Bosquet; Sachi Horibata; Joseph Heintz; Ralph Albrecht; Lucas Fass; Justanjyot Kaur; Kevin Hu; Hadi Shojaei; Rebecca J Whelan; Manish S Patankar
Journal:  Mol Cancer       Date:  2014-05-29       Impact factor: 27.401

8.  Integrated Microfluidic Lectin Barcode Platform for High-Performance Focused Glycomic Profiling.

Authors:  Yuqin Shang; Yun Zeng; Yong Zeng
Journal:  Sci Rep       Date:  2016-02-02       Impact factor: 4.379

9.  CA125-Tn ELISA assay improves specificity of pre-operative diagnosis of ovarian cancer among patients with elevated serum CA125 levels.

Authors:  Yi-Sheng Wang; Shi-Fang Ren; Wei Jiang; Jia-Qi Lu; Xiao-Yan Zhang; Xiao-Ping Li; Rui Cao; Cong-Jian Xu
Journal:  Ann Transl Med       Date:  2021-05
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.